Celanese Corporation (NYSE:CE – Get Free Report) has been given an average recommendation of “Hold” by the twenty ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and seven have given a buy rating to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $56.1111.
Several equities analysts have weighed in on CE shares. Robert W. Baird cut their target price on Celanese from $67.00 to $50.00 and set an “outperform” rating on the stock in a report on Wednesday, August 13th. BMO Capital Markets decreased their price target on Celanese from $55.00 to $47.00 and set a “market perform” rating for the company in a research note on Thursday, August 14th. Deutsche Bank Aktiengesellschaft set a $52.00 price target on Celanese and gave the stock a “buy” rating in a research note on Wednesday, August 13th. Mizuho upped their price target on Celanese from $50.00 to $59.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 15th. Finally, Wells Fargo & Company decreased their price target on Celanese from $60.00 to $57.00 and set an “overweight” rating for the company in a research note on Tuesday, September 30th.
View Our Latest Stock Analysis on Celanese
Insider Transactions at Celanese
Institutional Investors Weigh In On Celanese
Several hedge funds have recently made changes to their positions in the stock. Net Worth Advisory Group bought a new stake in shares of Celanese in the third quarter valued at about $272,000. Assenagon Asset Management S.A. lifted its stake in shares of Celanese by 437.9% in the third quarter. Assenagon Asset Management S.A. now owns 737,289 shares of the basic materials company’s stock valued at $31,025,000 after buying an additional 600,229 shares during the period. Sanders Morris Harris LLC bought a new stake in shares of Celanese in the third quarter valued at about $210,000. Osaic Holdings Inc. lifted its stake in shares of Celanese by 28.5% in the second quarter. Osaic Holdings Inc. now owns 4,503 shares of the basic materials company’s stock valued at $249,000 after buying an additional 998 shares during the period. Finally, Hudson Bay Capital Management LP lifted its stake in shares of Celanese by 138.5% in the second quarter. Hudson Bay Capital Management LP now owns 100,165 shares of the basic materials company’s stock valued at $5,542,000 after buying an additional 58,165 shares during the period. Institutional investors own 98.87% of the company’s stock.
Celanese Trading Down 1.5%
Celanese stock opened at $40.19 on Friday. The company’s fifty day simple moving average is $44.39 and its 200-day simple moving average is $49.21. The company has a quick ratio of 1.22, a current ratio of 2.05 and a debt-to-equity ratio of 2.22. Celanese has a 12 month low of $36.29 and a 12 month high of $136.68. The stock has a market cap of $4.40 billion, a P/E ratio of -2.71, a P/E/G ratio of 1.87 and a beta of 1.13.
Celanese (NYSE:CE – Get Free Report) last posted its quarterly earnings results on Monday, August 11th. The basic materials company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.38 by $0.06. Celanese had a negative net margin of 16.30% and a positive return on equity of 10.48%. The business had revenue of $2.53 billion for the quarter, compared to analysts’ expectations of $2.50 billion. During the same period in the previous year, the company posted $2.38 EPS. Celanese’s revenue was down 4.5% on a year-over-year basis. Celanese has set its Q3 2025 guidance at 1.100-1.400 EPS. As a group, sell-side analysts forecast that Celanese will post 8.79 EPS for the current fiscal year.
About Celanese
Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. It operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics.
See Also
- Five stocks we like better than Celanese
- What is the NASDAQ Stock Exchange?
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What to Know About Investing in Penny Stocks
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Stock Splits, Do They Really Impact Investors?
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Celanese Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celanese and related companies with MarketBeat.com's FREE daily email newsletter.